Park Hyo-Min, Park Jae-Young, Kim Na-Yeon, Kim Hyemoon, Kim Hong-Gyum, Son Dong-Ju, Hong Jin Tae, Yoon Do-Young
Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.
Boson Bioscience, Cheongju 28161, Korea.
Immune Netw. 2024 Jun 24;24(3):e27. doi: 10.4110/in.2024.24.e27. eCollection 2024 Jun.
The tumor microenvironment (TME) is formed by several immune cells. Notably, tumor-associated macrophages (TAMs) are existed in the TME that induce angiogenesis, metastasis, and proliferation of cancer cells. Recently, a point-mutated variant of IL-32θ was discovered in breast cancer tissues, which suppressed migration and proliferation through intracellular pathways. Although the relationship between cancer and IL-32 has been previously studied, the effects of IL-32θ on TAMs remain elusive. Recombinant human IL-32θ (rhIL-32θ) was generated using an expression system. To induce M0 macrophage polarization, THP-1 cells were stimulated with PMA. After PMA treatment, the cells were cultured with IL-4 and IL-13, or rhIL-32θ. The mRNA level of M1 macrophage markers (IL-1β, TNFα, inducible nitric oxide synthase) were increased by rhIL-32θ in M0 macrophages. On the other hand, the M2 macrophage markers (CCL17, CCL22, TGFβ, CD206) were decreased by rhIL-32θ in M2 macrophages. rhIL-32θ induced nuclear translocation of the NF-κB via regulation of the MAPK (p38) pathway. In conclusion, point-mutated rhIL-32θ induced the polarization to M1-like macrophages through the MAPK (p38) and NF-κB (p65/p50) pathways.
肿瘤微环境(TME)由多种免疫细胞构成。值得注意的是,肿瘤相关巨噬细胞(TAM)存在于TME中,可诱导癌细胞的血管生成、转移和增殖。最近,在乳腺癌组织中发现了IL-32θ的一个点突变变体,其通过细胞内途径抑制迁移和增殖。尽管此前已对癌症与IL-32之间的关系进行过研究,但IL-32θ对TAM的影响仍不清楚。使用表达系统制备了重组人IL-32θ(rhIL-32θ)。为诱导M0巨噬细胞极化,用佛波酯(PMA)刺激人单核细胞白血病细胞系(THP-1)细胞。PMA处理后,将细胞与IL-4和IL-13或rhIL-32θ一起培养。rhIL-32θ可使M0巨噬细胞中M1巨噬细胞标志物(IL-1β、肿瘤坏死因子α、诱导型一氧化氮合酶)的mRNA水平升高。另一方面,rhIL-32θ可使M2巨噬细胞中M2巨噬细胞标志物(CCL17、CCL22、转化生长因子β、CD206)减少。rhIL-32θ通过调节丝裂原活化蛋白激酶(p38)途径诱导核因子κB(NF-κB)的核转位。总之,点突变的rhIL-32θ通过丝裂原活化蛋白激酶(p38)和核因子κB(p65/p50)途径诱导极化形成M1样巨噬细胞。